Product Description
Overall, the global atherectomy device market was valued at $915 million in 2023. This is expected to increase over the forecast period at a CAGR of 4.2% to reach $1.2 billion.
Throughout this medical market research, we analyzed over 15 atherectomy device companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for atherectomy devices extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Atherectomy Device Market Insights
The intravascular atherectomy market is shifting towards minimally invasive and precision-based approaches due to technological advancements and a rising demand for better patient outcomes. The next generation of atherectomy devices with improved navigation, real-time imaging, and enhanced plaque removal efficiency are driving this trend. This shift from traditional surgical methods to targeted intravascular interventions is expanding the market, offering improved treatment options for atherosclerosis patients.
Global Atherectomy Device Market Share Insights
- Cardiovascular Systems, Inc. plays a significant role in the intravascular atherectomy device market, offering the Diamondback 360® and Stealth 360® systems. The Diamondback 360® is an advanced version of rotablator technology, minimizing procedural side effects like restenosis and vessel perforation. It holds a strong position, particularly in below-the-knee (BTK) procedures, and boasts usage rates exceeding industry averages for both above-the-knee (ATK) and BTK interventions
- Medtronic‘s influence in the intravascular atherectomy device market has been shaped by strategic acquisitions, including Covidien and ev3. The 2010 acquisition of ev3 by Covidien propelled Medtronic to market leadership. In 2023, HawkOne™ led in hospital market revenue for Medtronic.
- In 2017, Philips entered the laser atherectomy market through the acquisition of Spectranetics, offering the CVX-300 Excimer® and Nexcimer Laser System, along with the Turbo® catheter line. Philips expanded its laser atherectomy presence in 2022, holding a competitive edge with its unique ability to address both soft plaque and calcium using laser and mechanical tools.
Market Segmentation Summary
- Laser Atherectomy Device Market
- Mechanical Atherectomy Device Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
